Alpha Sense BI

MARCH 13, 2024

This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. M&A will serve as an avenue for pharmaceutical companies and start-ups to continue making significant advancements in their respective fields.

Pharmaceutical 59

Pharmaceutical Hospitals Due Diligence Biotech 59

Alpha Sense BI

DECEMBER 12, 2023

AlphaSense, a leading AI-based market intelligence platform , provides Expert Insights alongside an extensive universe of private, public, and premium content. These intangible factors indicate that even the most exhaustive due diligence processes can still leave gaps in the M&A research process.

Due Diligence 52

Due Diligence Primary Research Competitive Intelligence Market Intelligence 52

Alpha Sense BI

FEBRUARY 6, 2024

This research often includes assessing the financial performance, market potential, competitive landscape, regulatory environment and growth potential of target healthcare companies, drugs, medical technologies, treatments and more.

Research 98

Research Primary Research Due Diligence Competitive Positioning 98

Alpha Sense BI

MARCH 21, 2024

Expert networks are a critical tool for market intelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. AlphaSense, a leading market intelligence platform, has disrupted the expert network industry by providing Expert Insights with powerful AI search technology.

Primary Research 59

Primary Research Due Diligence SWOT Pharmaceutical 59

Alpha Sense BI

DECEMBER 15, 2023

Since the inception of the COVID-19 pandemic , artificial intelligence (AI) has ushered in a transformative era in drug discovery , development, and healthcare. Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately.

Pharmaceutical 52

Pharmaceutical Algorithm Predictive Analytics Research 52

CIO

JANUARY 3, 2024

Putting aside the fact this is an astronomically high adoption rate for a brand new technology, it’s also an indicator of how risky this space is. When assessing vendors, Rich Products looks at their technology, architecture, business value, and pragmatic perspective. A startup can easily become obsolete in any area of technology.

Alliance 763

Alliance Due Diligence Pharmaceutical Technology 763

Alpha Sense BI

FEBRUARY 3, 2023

Without an official system to check an organization’s commitment to its ESG policies, many shareholders and investors are doing their due diligence through fact-checking. And to accomplish this, more and more businesses are embracing digital transformation by adopting intelligent spending and business network technologies.

Finance 98

Finance Due Diligence Banking Pharmaceutical 98